CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,067,273
+$3,564,927 QoQ
Shares Held
941,285
-0.5% QoQ
Ownership
0.674%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. NTLA ranks #88 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,067,273 | 941,285 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,502,346 | 945,756 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,079,956 | 873,188 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,034,429 | 856,549 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,547,392 | 780,224 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $9,182,133 | 787,490 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $17,006,049 | 827,545 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,676,417 | 789,831 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,035,395 | 728,295 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $21,349,951 | 700,228 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $21,540,840 | 681,241 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $38,851,799 | 952,717 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $32,394,040 | 869,172 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,143,895 | 892,631 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $43,199,721 | 771,975 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,927,913 | 713,445 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $50,604,989 | 696,367 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $80,630,339 | 681,921 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $89,454,171 | 666,822 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $74,040,957 | 457,297 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $34,607,240 | 431,216 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $20,151,555 | 370,433 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,793,830 | 341,742 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,322,921 | 300,805 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,019,317 | 246,878 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||